Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-001052
Filing Date
2025-02-12
Accepted
2025-02-12 10:51:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5164
  Complete submission text file 0001085146-25-001052.txt   6931
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Subject) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88073 | Film No.: 25613051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE SOUTH STREET, SUITE 2550 BALTIMORE MD 21202
Business Address ONE SOUTH STREET, SUITE 2550 BALTIMORE MD 21202 410-454-3130
Patient Capital Management, LLC (Filed by) CIK: 0001854794 (see all company filings)

EIN.: 844277115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A